Scatter factor binds to thrombospondin and other extracellular matrix components

American Journal of Pathology

Volumn 149, Issue 3, 1996, Pages 805-819

  Lamszus, Katrin ^a   Joseph, Ansamma ^c   Jin, Liang ^a   Yao, Yan ^a   Chowdhury, Soheli ^a   Fuchs, Alexander ^a   Polverini, Peter J ^b   Goldberg, Itzhak D ^a   Rosen, Eliot M ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c Long Island Jewish Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; SCATTER FACTOR; THROMBOSPONDIN;

ANGIOGENESIS; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; BINDING, COMPETITIVE; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; FEMALE; HEPARIN; HEPATOCYTE GROWTH FACTOR; HUMANS; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; THROMBOSPONDINS; TUMOR CELLS, CULTURED;

EID: 0029764443     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Rosen EM, Nigam SK, Goldberg ID: Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 1994, 127:1783-1787
2. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993, 90:1937-1941
3. Rosen EM, Goldberg ID: Scatter factor and angiogenesis. Adv Cancer Res 1995, 67:257-279
4. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 1992, 3:65-71
5. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991, 251:802-804
6. Rosen EM, Knesel J, Goldberg ID, Jin L, Bhargava M, Joseph A, Zitnik R, Wines J, Kelley M, Rockwell S: Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor, Int J Cancer 1994, 57:706-714
7. Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O'Shaugnessy P, Goldberg ID, Rosen EM: Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 1995, 87:372-377
8. Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z: Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 1990, 9:203-226
9. Kelly JL, Sanchez A, Brown GS, Chesterman CN, Sleigh MJ: Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix. J Cell Biol 1993, 121:1153-1163
10. Park JE, Keller G-A, Ferrara N: The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993, 4:1317-1326
11. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE: Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J Biol Chem 1994, 269: 26775-26782
12. Rosen EM, Goldberg ID, Kacinski BM, Buckholz T, Vinter DW: Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol 1989, 25:163-173
13. Zarnegar R, Muga S, Rahija R, Michalopoulos G: Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes. Proc Natl Acad Sci USA 1990, 87:1252-1256
14. Mizuno K, Inoue H, Hagiya M, Shimizu S, Nose T, Shimohigashi Y, Nakamura T: Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J Biol Chem 1994, 269:1131-1136
15. Chan AM-L, Rubin JS, Bottaro DP, Hirschfield DW, Chedid M, Aaronson SA: Identification of a competitive antagonist encoded by an alternative transcript. Science 1991, 254:1382-1385
16. Cioce V, Csaky KG, Chan AM-L, Bottaro DP, Taylor WG, Jemsen R, Aaronson SA, Rubin JS. HGF/NK1 is a naturally occurring HGF/SF variant with partial agonist/ antagonist activity. J Biol Chem 1996, 271:13110-13115
17. Silverstein RL, Leung LL, Harpel PC, Nachman RL: Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine rich glycoprotein. J Clin Invest 1985, 75:2065-2073
18. Clezardin P, Malaval L, Ehrensperger AS, Delmas PD, Dechavanne M, McGregor JL: Complex formation of human thrombospondin with osteonectin. Eur J Biochem 1988, 175:275-284
19. Silverstein RL, Nachman RL, Pannell R, Gurewich V, Harpel PC: Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. J Biol Chem 1990, 265:11289-11294
20. Westphal M, Nausch H, Zirkel D: Cell culture of human brain tumors on extracellular matrices: methodology and biologic applications. Methods in Molecular Biology, vol 20: Human Cell Culture Protocols. Edited by GE Jones. Totowa, NJ, Humana Press, 1996 (in press)
21. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993, 122:497-511
22. Polverini PJ, Leibovich SJ: Induction of neovascularization in vivo and endothelial cell proliferation in vivo by tumor-associated macrophages. Lab Invest 1984, 51: 635-642
23. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443
24. Lawler J: Thrombospondin. Guidebook to the Extracellular Matrix and Adhesion Proteins. Edited by T Kreis, R Vale. New York, Oxford University Press, 1993, pp 95-96
25. Bornstein P: Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995, 130:503-506
26. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S, Vande Woude GF: Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 1992, 12:5152-5158
27. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK, Birchmeier W, Comoglio PM: Scatter factor and hepatocyte growth factor are indistinguishable ligands for the met receptor. EMBO J 1991, 10:2867-2878
28. Naka D, Ishii T, Shimomura T, Hishida T, Hara H: Heparin modulates the receptor-binding of hepatocyte growth factor on hepatocytes. Exp Cell Res 1993, 209: 317-324
29. Masumoto A, Yamamoto N: Stimulation of DNA synthesis in hepatocytes by hepatocyte growth factor bound to extracellular matrix. Biochem Biophys Res Commun 1993, 191:1218-1223
30. Kato S, Ishii T, Hara H, Sugiura N, Kimata K, Akamatsu N: Hepatocyte growth factor immobilized onto culture substrates through heparin and matrigel enhances DNA synthesis in primary rat hepatocytes. Exp Cell Res 1994, 211:53-56
31. Guo N, Krutzsch HC, Negre E, Zabrenetzky, Roberts DD: Heparin-binding peptides from the type I repeats of thrombospondin. 1992, 267:19349-19355
32. Rosen EM, Joseph A, Jing L, Rockwell S, Elias JA, Knese J, Wines J, McClellan J, Kluger MJ, Goldberg ID, Zitnik R: Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 1994, 127:225-234
33. Wang Y, Selden AC, Morgan N, Stamp GW, Hodgson HJ: Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 1994, 144:675-682
34. Benezra M, Vlodavsky I, Ishai-Michaeli R, Neufeld G, Bar Shavit R: Thrombin-induced release of active basic fibroblast growth factor-heparin sulfate complexes from subendothelial extracellular matrix. Blood 1993, 81:3324-3331
35. Schlesinger J, Lax I, Lemmon M: Regulation of growth factor activation by proteoglycans: what is the role of low affinity receptors? Cell 1995, 83:357-360
36. Taipale J, Miyazono K, Heldin CH, Keski OJ: Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 1994, 124:171-181
37. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH: The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 1992, 89:1281-1285
38. Khachigian LM, Chesterman CN: Structural basis for the extracellular retention of PDGF A-chain using a synthetic peptide corresponding to exon 6. Peptides 1994, 15:133-137
39. Tuszynski GP, Nicosia RF: Localization of thrombospondin and its cysteine-serine-valine-threonin-cysteine-glycine-specific receptor in human breast carcinoma. Lab Invest 1994, 70:228-233
40. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, Shin S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994, 54:1630-1633
41. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990, 87:6624-6628
42. Taraboletti G, Roberts D, Liotta LA, Giavazzi R: Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 1990, 111:765-772
43. DiPietro LA, Nebgen DR, Polverini PJ: Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res 1994, 31:178-185
44. Weinstat-Saslow DL, Zabrenetzky VS, Van Houtte K, Frazier WA, Roberts DD, Steeg PS: Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 1994, 54:6504-6511
45. Pratt DA, Miller WR, Dawes J: Thrombospondin in malignant and non-malignant breast tissue. Eur J Cancer Clin Oncol 1989, 25:343-350
46. Wong SY, Purdie AT, Han P: Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am J Pathol 1992, 140:1473-1482
47. Clezardin P, Frappart L, Clerget M, Pechoux P, Delmas PD: Expression of thrombospondin and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res 1993, 53:1421-1430
48. Koch AE, Friedman J, Burrows JC, Haines GK, Bouck NP: Localization of the angiogenesis inhibitor thrombospondin in human synovium tissues. Pathobiology 1993, 61:1-6
49. Yoshinaga Y, Matsuno Y, Fujita S, Nakamura T, Kikuchi M, Shimosato Y, Hirohashi S: Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 1993, 84:1150-1158
50. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
51. Weidner N, Folkman J, Pozza F, Bevilaqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992, 84:1875-1887
52. Nicosia RF, Tuszynski GP: Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol 1994, 124:183-193
53. Swerlick RA, Lee KH, Wick TM, Lawley TJ: Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 1992, 148:78-83
54. Hofmann R, Joseph A, Bhargava MM, Rosen E, Goldberg ID: Scatter factor is a glycoprotein, but glycosylation is not required for its activity. Biochem Biophys Acta 1992, 1120:343-350